Skip to main content
. 2020 Oct 15;11:566548. doi: 10.3389/fendo.2020.566548

Figure 2.

Figure 2

Glucose control during conditions of ± glucose infusion and ± exercise. (A) Time course for glucose concentration (mmol/L) during each experimental trial. (B) The mean glucose concentration (mmol/L) during each 3.5 h ± infusion period. *P < 0.05 (HG-Ex, d = 2.38; FG-Ex, d = 4.02) vs. CON. P < 0.05 (HG-Ex, d = 2.17; FG-Ex, d = 3.83) vs. NG-Ex. (C) Glucose iAUC during each 3.5 h ± infusion period. *P < 0.05 (HG-Ex, d = 2.47; FG-Ex, d = 4.40) vs. CON. P < 0.05 (HG-Ex, d = 2.70; FG-Ex, d = 4.94) vs. NG-Ex. (D) Glycemic variability (coefficient of variation; %CV) during each 3.5 h ± infusion period. *P < 0.05 (HG-Ex, d = 3.35; FG-Ex, d = 12.05) vs. CON. P < 0.05 (HG-Ex, d = 3.38; FG-Ex, d = 11.45) vs. NG-Ex. §P < 0.05 (FG-Ex, d = 4.84) vs. HG-Ex.